Beena Thannickal

Beena Thannickal

| This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Specialist, UAB News
(205) 975-3967
beenat@uab.edu

Thannickal recently moved to Birmingham from Ann Arbor, Mich., where she was the senior PR specialist at the Institute for Research on Women and Gender at the University of Michigan. She previously worked at Boston University, specializing in research and science news, and she worked at PR firms in New York and Boston. While raising her three children she was a freelance writer for a women’s health magazine and a PR consultant for national clients. Beena’s professional roots started in Connecticut where she worked as a reporter at news organizations throughout the state. She has a bachelor's degree in journalism from the University of Connecticut. In her very little spare time, she likes to run and travel.

Beats: The UAB Comprehensive Cancer Center, cancer patient stories, cancer-related research
The UAB Comprehensive Cancer Center has developed a statewide coalition to increase uptake of HPV vaccinations in Alabama.
UAB receives American Cancer Society grant to foster early career development in junior faculty conducting cancer research.
Research on using patient navigation as a means to increase participation of minorities in clinical trials is among this year’s top clinical cancer research advances.
UAB has joined forces with the American Cancer Society in the “80 by 18” initiative to actively promote colorectal cancer screening among its employees.
Artists will create spectacular works of art in the blink of an eye during the UAB Comprehensive Cancer Center’s annual ArtBLINK Gala 2016 at 6:30 p.m. Saturday, Feb. 20, in The Kirklin Clinic, 2000 Sixth Ave. South.
New UAB research study shows therapeutic promise in targeting MLK4 in brain cancer patients.
In a joint statement of National Cancer Institute-designated cancer centers, the UAB Comprehensive Cancer Center urges parents, young adults and physicians to increase HPV vaccination rates.
The Nov. 10 workshop will provide information and resources for lung cancer patients.
UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.
Several activities are planned in and around UAB for Breast Cancer Awareness Month.
Page 1 of 6